Alcohol Use Disorders in Alcoholic Liver Disease.
Addiction
Alcohol dependence
Biomarkers
Multidisciplinary care
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
entrez:
21
11
2018
pubmed:
21
11
2018
medline:
17
9
2019
Statut:
ppublish
Résumé
Alcohol use disorder (AUD) is common in alcoholic liver disease (ALD) and intrinsic to its pathophysiology. Optimal treatment requires a multidisciplinary team approach and a working alliance between patients and providers. Diagnosing AUD involves a combination of thorough history taking, physical examination, screening questionnaires, and alcohol biomarkers. Alcohol biomarkers have advantages and limitations of use of which clinicians should be aware. AUD treatment is effective, multifaceted, and can be tailored to each individual. Available treatment modalities are myriad: motivational enhancement therapy, cognitive behavior therapy, 12-step facilitation, group therapies, intensive outpatient programs, inpatient and residential treatment, and relapse prevention medications.
Identifiants
pubmed: 30454833
pii: S1089-3261(18)30080-1
doi: 10.1016/j.cld.2018.09.004
pii:
doi:
Substances chimiques
Alcohol Deterrents
0
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-69Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.